EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Lithospermic Acid Improves Doxorubicin‐Induced Cardiomyopathy Through Sirtuin‐3‐Mediated Deacetylation of p53

Yining Zhao, Tao Xu, Chao Ye iD, Ke Zhang, Xinyu Heng, Shaohong Huang, Yan Chen, Yitong Guo, Shengyi Shao, Zhi Wen, Chenwen Shao, Xiang Lu and 2 more

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70188 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Yining Zhao and 13 co-authors. Institution: Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China. Major MEDLINE topics: Doxorubicin, Tumor Suppressor Protein p53, Cardiomyopathies, Depsides. 58 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, National Science and Technology Major Project, Basic Research Program of Jiangsu.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Doxorubicin (Dox)‐induced cardiomyopathy (DIC) is characterized by significant myocardial damage that can progress to dilated cardiomyopathy and potentially lead to heart failure. The rate of mortality due to heart disease in patients undergoing cancer chemotherapy has even surpassed that caused by tumor recurrence. However, there is a lack of effective treatments for DIC in clinical practice. Lithospermic acid (LA), a polycyclic phenolic carboxylic acid isolated from the traditional Chinese herb Salvia miltiorrhiza , exhibits superior efficacy in inhibiting oxidative stress damage across various diseases. This study aimed to assess the therapeutic potential of LA in alleviating cardiac injury and elucidate its potential molecular mechanisms in DIC. Male C57BL/6J mice were randomly divided into four groups: saline control, saline with LA, Dox, and LA combined with Dox. A mouse cardiomyocyte cell line HL‐1, along with human embryonic stem cells‐derived cardiomyocytes, was utilized to investigate the therapeutic potential of LA on Dox‐induced cardiomyocyte injury in vitro. Supplementation with exogenous LA mitigated Dox‐induced cardiac atrophy, cardiac fibrosis, and ventricular remodeling while preserving cardiac function. LA reduced Dox‐induced abnormal cardiomyocyte apoptosis and excessive oxidative stress both in vitro and in vivo. Dox promoted the acetylation of p53 by decreasing the expression of sirtuin‐3 (SIRT3), which triggered continuous oxidative stress and apoptosis. LA enhanced the deacetylation of p53 and subsequently inhibited the activation of the p53 signaling pathway by directly targeting SIRT3. Knockdown of SIRT3 eliminated the beneficial effects of LA against Dox. LA serves as a beneficial treatment for Dox‐induced pathological cardiac injury and remodeling by targeting SIRT3, thereby enhancing the deacetylation of p53. This study provides novel insights into the potential of LA as a promising drug candidate for cardio‐protection.

Subjects

MeSH terms (MEDLINE)

DoxorubicinTumor Suppressor Protein p53CardiomyopathiesDepsidesBenzofuransSirtuin 3AnimalsMaleMiceMyocytes, CardiacAcetylationMice, Inbred C57BLOxidative StressApoptosisHumansCell Line

Author keywords

SIRT3doxorubicin‐induced cardiomyopathylithospermic acidp53 acetylationp53 signaling

Substances

DoxorubicinTumor Suppressor Protein p53DepsidesBenzofuransSirtuin 3Trp53 protein, mousesalvianolic acid BSirt3 protein, mouse

Authors and institutions

  • Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
  • MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
  • Department of Geriatrics, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Cardiology, Affiliated Children's Hospital of Jiangnan University (Wuxi Children's Hospital), Jiangnan University, Wuxi, Jiangsu, China.
  • Department of Laboratory Medicine, The Affiliated Xuancheng Hospital of Wannan Medical College, Xuancheng, China.

ORCID profiles: Chao Ye

Funding

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Basic Research Program of Jiangsu
  • Jiangsu Funding Program for Excellent Postdoctoral Talent
  • Medical Discipline Development Fund of Jiangnan University

Cite

APA

Zhao, Y., Xu, T., Ye, C., Zhang, K., Heng, X., Huang, S., Chen, Y., Guo, Y., Shao, S., Wen, Z., Shao, C., Lu, X., Sun, N., & Yang, H. (2026). Lithospermic Acid Improves Doxorubicin‐Induced Cardiomyopathy Through Sirtuin‐3‐Mediated Deacetylation of p53. Phytotherapy Research. https://doi.org/10.1002/ptr.70188

Vancouver

Zhao Y, Xu T, Ye C, Zhang K, Heng X, Huang S, et al. Lithospermic Acid Improves Doxorubicin‐Induced Cardiomyopathy Through Sirtuin‐3‐Mediated Deacetylation of p53. Phytotherapy Research. 2026. doi:10.1002/ptr.70188

BibTeX
@article{Zhao2026,
  author = {Zhao, Yining and Xu, Tao and Ye, Chao and Zhang, Ke and Heng, Xinyu and Huang, Shaohong and Chen, Yan and Guo, Yitong and Shao, Shengyi and Wen, Zhi and Shao, Chenwen and Lu, Xiang and Sun, Ning and Yang, Hai},
  title = {Lithospermic Acid Improves Doxorubicin‐Induced Cardiomyopathy Through Sirtuin‐3‐Mediated Deacetylation of p53},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70188}
}
Start for free →